- Q4 2024 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2024₹1032.3 (+0.28%)Earnings
- Q3 2024 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2024₹887.1 (+0.26%)Earnings
- Q2 2024 Natco Pharma Ltd Earnings Call TranscriptNov 15, 2023₹758.65 (-4.48%)Earnings
- Natco Pharma Ltd Annual Shareholders Meeting TranscriptSep 29, 2023
- Q1 2024 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2023₹876.05 (-1.97%)Earnings
- Q4 2023 Natco Pharma Ltd Earnings Call TranscriptMay 30, 2023₹619.5 (-2.15%)Earnings
- Q3 2023 Natco Pharma Ltd Earnings Call TranscriptFeb 10, 2023₹524.85 (-0.88%)Earnings
- Q2 2023 Natco Pharma Ltd Earnings Call TranscriptNov 11, 2022₹584 (-0.72%)Earnings
- Q1 2023 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2022₹672.85 (-10.35%)Earnings
- Q4 2022 Natco Pharma Ltd Earnings Call TranscriptMay 31, 2022₹690.95 (+3.72%)Earnings
- Q3 2022 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2022₹895.35 (-2.40%)Earnings
- Q2 2022 Natco Pharma Ltd Earnings Call TranscriptNov 12, 2021₹828.7 (+0.55%)Earnings
- Q1 2022 Natco Pharma Ltd Earnings Call TranscriptAug 12, 2021₹1041.45 (+3.06%)Earnings
- Q4 2021 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2021₹1095.8 (+1.25%)Earnings
- Q3 2021 Natco Pharma Ltd Earnings Call TranscriptFeb 12, 2021₹854 (-3.64%)Earnings
- Q2 2021 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2020₹900.9 (-0.63%)Earnings
- Q1 2021 Natco Pharma Ltd Earnings Call TranscriptAug 13, 2020₹813.4 (-4.17%)Earnings
- Q4 2020 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2020₹620.05 (+0.99%)Earnings
- Q3 2020 Natco Pharma Ltd Earnings Call TranscriptFeb 13, 2020₹673.95 (-4.91%)Earnings
- Q2 2020 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2019₹560.15 (-3.19%)Earnings
- Q1 2020 Natco Pharma Ltd Earnings Call TranscriptAug 09, 2019₹551.45 (-0.27%)Earnings
- Q4 2019 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2019₹529.9 (+0.94%)Earnings
Q3 2024 Natco Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Natco Pharma Q3 FY24 post-results earnings conference call hosted by Batlivala & Karani Securities India Private Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Hrishikesh Patole from B&K Securities India Private Limited. And over to you, sir.
Good morning everyone. On behalf of B&K Securities, I welcome all for FY24 earnings conference call of Natco Pharma.
Good morning, everyone. Thank you, Hrishikesh, again, welcome everyone to our conference call discussing our results for the third quarter of FY24, which ended December 31, 2023. Our discussion during this call will include certain forward-looking statements, which are predictions, projections or other estimates about future events.
While these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)